Home Amines 3990-59-8
3990-59-8,MFCD10697678
Catalog No.:AA00CLWO

3990-59-8 | Chroman-2-ylmethanamine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
95%
1 week  
$70.00   $49.00
- +
250mg
95%
1 week  
$97.00   $68.00
- +
1g
95%
1 week  
$240.00   $168.00
- +
5g
95%
1 week  
$1,190.00   $833.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA00CLWO
Chemical Name:
Chroman-2-ylmethanamine
CAS Number:
3990-59-8
Molecular Formula:
C10H13NO
Molecular Weight:
163.2163
MDL Number:
MFCD10697678
SMILES:
NCC1CCc2c(O1)cccc2
Properties
Computed Properties
 
Complexity:
149  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
12  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
1  
Undefined Atom Stereocenter Count:
1  
XLogP3:
1.4  

Downstream Synthesis Route

[1]Patent:US5767132,1998,A

161923-60-0    3990-59-8   
(E)-N-3-(3,4-dihydro-5-methoxy-1(2H)-naphthalenylidene)propyl-2-aminomethylchromane 

[1]MedicinalChemistryResearch,1999,vol.9,p.340-353

[1]JournalofMedicinalChemistry,2013,vol.56,p.9019-9030

[2]JournalofMedicinalChemistry,2005,vol.48,p.1941-1947

[3]Patent:US2007/155824,2007,A1.Locationinpatent:Page/Pagecolumn22

[4]Patent:WO2007/137167,2007,A2.Locationinpatent:Page/Pagecolumn40-41

[5]Patent:US2008/153871,2008,A1.Locationinpatent:Page/Pagecolumn20

[6]Patent:US2009/247616,2009,A1.Locationinpatent:Page/Pagecolumn17

[7]Patent:WO2006/7435,2006,A1.Locationinpatent:Page/Pagecolumn43-44

[8]Patent:US2007/155826,2007,A1.Locationinpatent:Page/Pagecolumn17-18

[9]Patent:WO2007/75833,2007,A2.Locationinpatent:Page/Pagecolumn39

[10]Patent:US2005/282887,2005,A1.Locationinpatent:Page/Pagecolumn19

3990-59-8   
N-(chroman-2-ylmethyl)sulfamide 

[1]JournalofMedicinalChemistry,2005,vol.48,p.1941-1947

[2]JournalofMedicinalChemistry,2013,vol.56,p.9019-9030

[3]Patent:US2007/155822,2007,A1.Locationinpatent:Page/Pagecolumn16-17

[4]Patent:WO2007/137167,2007,A2.Locationinpatent:Page/Pagecolumn40-41

[5]Patent:US2009/247616,2009,A1.Locationinpatent:Page/Pagecolumn17

[6]Patent:WO2006/7435,2006,A1.Locationinpatent:Page/Pagecolumn44

[7]Patent:US2007/155821,2007,A1.Locationinpatent:Page/Pagecolumn17

[8]Patent:US2007/155823,2007,A1.Locationinpatent:Page/Pagecolumn15

[9]Patent:US2007/155825,2007,A1.Locationinpatent:Page/Pagecolumn15

[10]Patent:US2007/155826,2007,A1.Locationinpatent:Page/Pagecolumn17-18

[11]Patent:US2007/155827,2007,A1.Locationinpatent:Page/Pagecolumn16

[12]Patent:WO2007/75833,2007,A2.Locationinpatent:Page/Pagecolumn39

[13]Patent:US2005/282887,2005,A1.Locationinpatent:Page/Pagecolumn19

[1]JournalofMedicinalChemistry,2005,vol.48,p.1941-1947

[2]Patent:US2007/155822,2007,A1.Locationinpatent:Page/Pagecolumn16

[3]Patent:US2007/155821,2007,A1.Locationinpatent:Page/Pagecolumn17

[4]Patent:US2007/155823,2007,A1.Locationinpatent:Page/Pagecolumn15

[5]Patent:US2007/155827,2007,A1.Locationinpatent:Page/Pagecolumn16

[6]Patent:US2007/191474,2007,A1.Locationinpatent:Page/Pagecolumn17

[7]JournalofMedicinalChemistry,2013,vol.56,p.9019-9030

Literature

Title: Repinotan Bayer.

Journal: Current opinion in investigational drugs (London, England : 2000) 20020601

Title: Inhibition of evoked glutamate release by the neuroprotective 5-HT(1A) receptor agonist BAY x 3702 in vitro and in vivo.

Journal: Brain research 20010105

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:3990-59-8 Molecular Formula|3990-59-8 MDL|3990-59-8 SMILES|3990-59-8 Chroman-2-ylmethanamine